JPMorgan Chase & Co’s Cabaletta Bio CABA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $123K | Sell |
80,796
-170,641
| -68% | -$259K | ﹤0.01% | 4708 |
|
|
2025
Q1 | $348K | Sell |
251,437
-7,955
| -3% | -$11K | ﹤0.01% | 4207 |
|
|
2024
Q4 | $589K | Sell |
259,392
-20,562
| -7% | -$46.7K | ﹤0.01% | 4077 |
|
|
2024
Q3 | $1.32M | Sell |
279,954
-676,735
| -71% | -$3.19M | ﹤0.01% | 3501 |
|
|
2024
Q2 | $7.16M | Buy |
956,689
+933,034
| +3,944% | +$6.98M | ﹤0.01% | 2326 |
|
|
2024
Q1 | $404K | Sell |
23,655
-21,185
| -47% | -$361K | ﹤0.01% | 4087 |
|
|
2023
Q4 | $1.02M | Buy |
44,840
+21,172
| +89% | +$481K | ﹤0.01% | 3521 |
|
|
2023
Q3 | $360K | Buy |
23,668
+3,204
| +16% | +$48.8K | ﹤0.01% | 3893 |
|
|
2023
Q2 | $264K | Buy |
20,464
+19,831
| +3,133% | +$256K | ﹤0.01% | 4127 |
|
|
2023
Q1 | $5K | Hold |
633
| – | – | ﹤0.01% | 5378 |
|
|
2022
Q4 | $6K | Sell |
633
-1,276
| -67% | -$12.1K | ﹤0.01% | 5179 |
|
|
2022
Q3 | $1K | Buy |
1,909
+311
| +19% | +$163 | ﹤0.01% | 5385 |
|
|
2022
Q2 | $2K | Sell |
1,598
-2,110
| -57% | -$2.64K | ﹤0.01% | 5405 |
|
|
2022
Q1 | $8K | Buy |
3,708
+849
| +30% | +$1.83K | ﹤0.01% | 5422 |
|
|
2021
Q4 | $11K | Sell |
2,859
-15,346
| -84% | -$59K | ﹤0.01% | 5419 |
|
|
2021
Q3 | $221K | Buy |
18,205
+5,603
| +44% | +$68K | ﹤0.01% | 4360 |
|
|
2021
Q2 | $108K | Sell |
12,602
-17,895
| -59% | -$153K | ﹤0.01% | 4740 |
|
|
2021
Q1 | $339K | Buy |
30,497
+4,575
| +18% | +$50.9K | ﹤0.01% | 4235 |
|
|
2020
Q4 | $323K | Buy |
25,922
+7,794
| +43% | +$97.1K | ﹤0.01% | 3975 |
|
|
2020
Q3 | $189K | Buy |
18,128
+3,093
| +21% | +$32.2K | ﹤0.01% | 3757 |
|
|
2020
Q2 | $167K | Buy |
15,035
+1,574
| +12% | +$17.5K | ﹤0.01% | 3744 |
|
|
2020
Q1 | $98K | Buy |
13,461
+11,336
| +533% | +$82.5K | ﹤0.01% | 3937 |
|
|
2019
Q4 | $30K | Buy |
+2,125
| New | +$30K | ﹤0.01% | 4357 |
|